With the price of gold cooling off over the last week, the roller-coaster ride for both the SPDR Gold Trust (NYSEMKT: GLD ) and for big miners like Goldcorp (NYSE: GG ) , Barrick Gold (NYSE: ABX ) , and Newmont Mining (NYSE: NEM ) is in full effect, and the rush back to gold seems over. A drop in demand would normally signal the end of a trend, but Dennis Gartman of "The Gartman Letter" urges us to think about gold in a new light 芒�� as a currency.
In the video below, Fool.com contributor Doug Ehrman discusses how gold might behave under this alternative understanding, the viability of such an approach for most, and the potential impact on the longer trend.
Goldcorp is one of the leading players in the gold mining market. For the last several years, investors have been the beneficiaries of several successful acquisitions and strong organic growth. Goldcorp's low-cost production of one of the most sought-after metals in the world continues to make this stock an attractive choice for long-term investors. To learn everything you need to know about this mining specialist, you're invited to check out The Motley Fool's premium research report on the company, which comes with a full year of ongoing updates and analysis to keep you informed as key news breaks. Click here now to claim your copy today.
Best Promising Stocks To Invest In Right Now: Crocs Inc.(CROX)
Crocs, Inc. and its subsidiaries engage in the design, development, manufacture, marketing, and distribution of footwear, apparel, and accessories for men, women, and children. The company primarily offers casual and athletic shoes, and shoe charms. It also designs and sells a range of footwear and accessories that utilize its proprietary closed cell-resin, called Croslite. The company?s footwear products include boots, sandals, sneakers, mules, and flats. In addition, it provides footwear products for the hospital, restaurant, hotel, and hospitality markets, as well as general foot care and diabetic-needs markets. Further, the company offers leather and ethylene vinyl acetate based footwear, sandals, and printed apparels principally for the beach, adventure, and action sports markets; and accessories comprising snap-on charms. The company sells its products through the United States and international retailers and distributors, as well as directly to end-user consumers th rough its company-operated retail stores, outlets, kiosks, and Web stores primarily under the Crocs Work, Crocs Rx, Jibbitz, Ocean Minded, and YOU by Crocs brand names. As of December 31, 2010, it operated 164 retail kiosks located in malls and other high foot traffic areas; 138 retail stores; 76 outlet stores; and 46 Web stores. Crocs, Inc. operates in the Americas, Europe, and Asia. The company was formerly known as Western Brands, LLC and changed its name to Crocs, Inc. in January 2005. Crocs, Inc. was founded in 1999 and is headquartered in Niwot, Colorado.
Advisors' Opinion:- [By Matt Brownell]
AOL When we spoke to Crocs (CROX) CEO John McCarvel back in January, we couldn't help but notice his choice of footwear: He wasn't wearing Crocs. But we couldn't really hold it against him. McCarvel was in town to accept an innovator award from the National Retail Federation, and Crocs didn't really make anything appropriate for the occasion. You can't wear Crocs with a suit, right? Well, that's not entirely true. As it turns out, Crocs now offers a number of shoes that are a bit more on the dressy side. They've got loafers, for instance, which could work at the country club. And for the office they've got the "Tummler" shoe, which combines the molded rubber clogs with a black leather slip-on dress shoe. As the website explains, it's meant to be a "work shoe you can live with." Around the same time we came across the Crocs dress shoe, we also became aware of another product that tries to combine stay-at-home comfort with office-appropriate wear: Dress pants-style sweatpants. These have all the comfort and warmth of a pair of sweatpants, but are designed like a pair of dress slacks, complete with back pockets, belt loops and pinstripes. Together, the Crocs dress shoes and sweatpants dress pants suggest a new paradigm for office wear: Dressy enough to pass muster with your boss, but comfortable enough that you can feel like you're having a pajama day working from home. But could you really pull this off in an office environment? To find out, I got a pair of each, then put them on and headed down to the offices of StyleList, Aol's fashion experts. I modeled my office wear for a panel of three StyleList editors: Ellen Thomas, Logan Sowa and Abby Silverman. Their first reaction was telling -- two of them didn't realize that I'd actually changed into the sweatpants. That, I thought, meant that I could get away with wearing sweatpants without anyone noticing. But on closer inspection, doubts started to emerge. "I don't think I'll ever be inclined to think this is
- [By Lisa Levin]
Crocs (NASDAQ: CROX) surged 5.40% to $16.78. The volume of Crocs shares traded was 191% higher than normal. Monness Crespi Hardt upgraded Crocs from Neutral to Buy.
- [By Matt Thalman]
In the following video, Fool contributor Matt Thalman discusses how the company known for its fashion faux pas rubber clog is attempting to change consumers' opinions about what it has to offer. Crocs (NASDAQ: CROX ) is making some big moves, and major strides toward strengthening its offerings and sales. With more than 300 different styles, the company is no longer just the rubber clog with holes in it. And, while that one product still generates more than 47% of the company's revenue, in other countries, it's not seen as such a terrible fashion statement as it is here in the U.S. The company is using that international strength and brand recognition as a way to grow its business.
5 Best Growth Stocks For 2015: MEDIFAST INC(MED)
Medifast, Inc., through its subsidiaries, engages in the production, distribution, and sale of weight management and disease management products, and other consumable health and diet products in the United States. The company?s product lines include weight and disease management, meal replacement, and vitamins. It also operates weight control centers that offer Medifast programs for weight loss and maintenance, customized patient counseling, and inbody composition analysis. The company markets its products under the Medifast and Essential brand names, including shakes, appetite suppression shakes, women?s health shakes, diabetics shakes, joint health shakes, coronary health shakes, calorie burn drinks, calorie burn flavor infusers, antioxidant shakes, antioxidant flavor infusers, bars, crunch bars, soups, chili, oatmeal, pudding, scrambled eggs, hot cocoa, cappuccino, chai latte, iced teas, fruit drinks, pretzels, puffs, brownie, pancakes, soy crisps, crackers, and omega 3 and digestive health products. Medifast Inc. sells its products through various channels of distribution comprising Web, call center, independent health advisors, medical professionals, weight loss clinics, and direct consumer marketing supported via the phone and the Web; Take Shape for Life, a physician led network of independent health coaches; and weight control centers. The company was founded in 1980 and is headquartered in Owings Mills, Maryland.
Advisors' Opinion:- [By Monica Gerson]
Medifast (NYSE: MED) is expected to post its Q4 earnings at $0.36 per share on revenue of $80.83 million.
Full House Resorts (NASDAQ: FLL) is estimated to post a Q4 loss at $0.06 per share on revenue of $33.24 million.
- [By Jon C. Ogg]
Medifast Inc. (NYSE: MED) saw its stock down 5% in evening trading on Tuesday after the weight loss player had soft sales and guided expectations lower. Shares were still indicated down about 5%, but volume has not yet started.
5 Best Growth Stocks For 2015: Intuitive Surgical Inc.(ISRG)
Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems for various surgical procedures, including urologic, gynecologic, cardiothoracic, general, and head and neck surgeries. Its da Vinci surgical system consists of a surgeon?s console or consoles, a patient-side cart, a 3-D vision system, and proprietary ?wristed? instruments. The company?s da Vinci surgical system translates the surgeon?s natural hand movements on instrument controls at the console into corresponding micro-movements of instruments positioned inside the patient through small puncture incisions, or ports. It also manufactures a range of EndoWrist instruments, which incorporate wrist joints for natural dexterity for various surgical procedures. Its EndoWrist instruments consist of forceps, scissors, electrocautery, scalpels, and other surgical tools. In addition, it sells various vision and accessory products for use in conjunction with the da Vinci Surgical System as surgical procedures are performed. The company?s accessory products include sterile drapes used to ensure a sterile field during surgery; vision products, such as replacement 3-D stereo endoscopes, camera heads, light guides, and other items. It markets its products through sales representatives in the United States, and through sales representatives and distributors in international markets. The company was founded in 1995 and is headquartered in Sunnyvale, California.
Advisors' Opinion:- [By Alex Planes]
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown. The best stocks offer sustainable market-beating gains, with robust and improving financial metrics that support strong price growth. Does Intuitive Surgical (NASDAQ: ISRG ) fit the bill? Let's look at what its recent results tell us about its potential for future gains.
- [By Selena Maranjian]
Among holdings in which Lone Pine Capital increased its stake are Intuitive Surgical (NASDAQ: ISRG ) and Ulta Salon (NASDAQ: ULTA ) . Intuitive Surgical, specializing in robotic surgical equipment, has had a bumpy year, thanks to bearish comments from a research company and questions about the efficacy of its systems. Some legal worries were eased recently, with a victory in court. While some wonder whether the company's growth prospects are slowing down, others love the company's competitive advantages and dominance in its promising market.
5 Best Growth Stocks For 2015: Thoratec Corporation(THOR)
Thoratec Corporation engages in the development, manufacture, and marketing of proprietary medical devices used for circulatory support. The company?s primary product lines include ventricular assist devices, such as HeartMate II, an implantable left ventricular assist device consisting of a rotary blood pump to provide intermediate and long-term mechanical circulatory support (MCS); and HeartMate XVE, an implantable and pulsatile left ventricular assist device for intermediate and longer-term MCS. Its ventricular assist devices also comprise Paracorporeal Ventricular Assist Device, an external pulsatile ventricular assist device, which provides left, right, and biventricular MCS approved for bridge-to-transplantation (BTT), including home discharge, and post-cardiotomy myocardial recovery; and Implantable Ventricular Assist Device, an implantable and pulsatile ventricular assist device designed to provide left, right, and biventricular MCS approved for BTT comprising hom e discharge, and post-cardiotomy myocardial recovery. The company also provides CentriMag, an extracorporeal full-flow acute surgical support platform that offers support up to 30 days for cardiac and respiratory failure. In addition, it offers PediMag and PediVAS extracorporeal full-flow acute surgical support platforms designed to provide acute surgical support to pediatric patients. The company sells its products through direct sales force in the United States, as well as through a network of distributors internationally. Thoratec Corporation was founded in 1976 and is headquartered in Pleasanton, California.
Advisors' Opinion:- [By Ali Berri]
In trading on Thursday, healthcare shares were relative laggards, down on the day by about 0.62 percent. Meanwhile, top decliners in the sector included Thoratec (NASDAQ: THOR), down 28.4 percent, and PhotoMedex (NASDAQ: PHMD), off 14.6 percent.
- [By Brian Pacampara]
What: Shares of medical device company Thoratec (NASDAQ: THOR ) sank 12% today after its quarterly results missed Wall Street expectations. �
- [By Anna Prior]
Medical device company Thoratec Corp.(THOR) has purchased Apica Cardiovascular Ltd., in a deal that includes $35 million in cash upfront and potential milestone payments of up to $40 million.
- [By Garrett Cook]
In trading on Thursday, healthcare shares were relative laggards, down on the day by about 0.62 percent. Meanwhile, top decliners in the sector included Thoratec (NASDAQ: THOR), down 30 percent, and PhotoMedex (NASDAQ: PHMD), off 15.11 percent.
